Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Theravance Biopharma, Inc. (TBPH)  
$9.14 0.03 (0.33%) as of 4:30 Thu 4/25


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 63,980,000
Market Cap: 584.78(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $8.22 - $11.59
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  245
Guru Rank Value     : 4.8
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Theravance Biopharma is a biopharmaceutical company primarily focused on the discovery, development and commercialization of respiratory medicine medicines. Co.'s program include: YUPELRI™ (revefenacin) inhalation solution, nebulized long-acting muscarinic antagonist for the maintenance treatment of chronic obstructive pulmonary disease; and Lung-selective, Nebulized Pan-Janus Kinase (JAK) Inhibitor (Nezulcitinib), a lung-selective, nebulized JAK inhibitor, in clinical development for the potential treatment of hospitalized patients with acute lung injury caused by Coronavirus Disease 2019.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 1,254 5,114 22,963 172,089
Total Sell Value $10,922 $50,468 $231,475 $1,835,193
Total People Sold 1 2 2 4
Total Sell Transactions 1 3 11 21
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 529
  Page 5 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Winningham Rick E CHIEF EXECUTIVE OFFICER   •       •      –    2022-02-25 4 A $0.00 $0 D/D 170,000 1,449,300     -
   Winningham Rick E CHIEF EXECUTIVE OFFICER   •       •      –    2022-02-18 4 D $9.61 $218,243 D/D (22,710) 1,279,300     -
   Graham Richard A SVP, DEVELOPMENT   •       –      –    2022-02-18 4 D $9.61 $195,823 D/D (20,377) 388,684     -
   Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER   •       –      –    2022-02-18 4 D $9.61 $249,601 D/D (25,973) 481,285     -
   Pitzer Kenneth R SVP, PROD STRAT & COMM PLNG   •       –      –    2022-02-18 4 D $9.61 $262,343 D/D (27,299) 380,123     -
   Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS   •       –      –    2022-02-18 4 D $9.61 $113,629 D/D (11,824) 335,627     -
   Brady Ann PRESIDENT, TBIL   •       –      –    2022-02-18 4 D $9.61 $80,426 D/D (8,369) 110,319     -
   Pitzer Kenneth R SVP, PROD STRAT & COMM PLNG   •       –      –    2022-02-07 4 A $0.00 $0 D/D 52,000 407,422     -
   Farnum Rhonda SVP, Comm & Medical Affairs   •       –      –    2021-12-14 4 A $0.00 $0 D/D 27,500 347,451     -
   Hindman Andrew A. SVP, Chief Financial Officer   •       –      –    2021-12-02 4 A $0.00 $0 D/D 340,000 507,258     -
   Graham Richard A SVP, Development   •       –      –    2021-12-02 4 A $0.00 $0 D/D 240,000 409,061     -
   Farnum Rhonda SVP, Comm & Medical AffairsOff   •       –      –    2021-12-01 3 IO $0.00 $0 D/D 0 319,951 16%     
   Graham Richard A SVP, Development   •       –      –    2021-08-20 4 D $14.05 $95,807 D/D (6,819) 173,205     -
   Winningham Rick E Chief Executive Officer   •       •      –    2021-08-20 4 D $14.05 $160,226 D/D (11,404) 1,313,414     -
   Shafer Bradford J EVP, Gen. Counsel, Secretary   •       –      –    2021-08-20 4 D $14.05 $60,513 D/D (4,307) 277,831     -
   Sabesan Vijay SVP, Technical Operations   •       –      –    2021-08-20 4 D $14.05 $72,962 D/D (5,193) 240,715     -
   Pasqualone Frank SVP, Chief Business Officer   •       –      –    2021-08-20 4 D $14.05 $53,095 D/D (3,779) 433,562     -
   Hindman Andrew A. SVP, Chief Financial Officer   •       –      –    2021-08-20 4 D $14.05 $245,369 D/D (17,464) 167,380     -
   Brady Ann President, TBIL   •       –      –    2021-08-20 4 D $14.05 $44,524 D/D (3,169) 121,857     -
   Worboys Philip D SVP, Research & Transl Science   •       –      –    2021-08-20 4 D $14.05 $60,513 D/D (4,307) 335,062     -
   Pitzer Kenneth R SVP, Prod Strat & Comm Plng   •       –      –    2021-08-20 4 D $14.05 $60,513 D/D (4,307) 359,732     -
   Shafer Bradford J EVP, Gen. Counsel, Secretary   •       –      –    2021-05-20 4 D $17.80 $76,718 D/D (4,310) 282,138     -
   Worboys Philip D SVP, Research & Transl Science   •       –      –    2021-05-20 4 D $17.80 $76,718 D/D (4,310) 339,369     -
   Sabesan Vijay SVP, Technical Operations   •       –      –    2021-05-20 4 D $17.80 $92,453 D/D (5,194) 245,908     -
   Hindman Andrew A. SVP, Chief Financial Officer   •       –      –    2021-05-20 4 D $17.80 $16,768 D/D (942) 184,844     -
  529 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us